LSE:AZNPharmaceuticals
Assessing AstraZeneca’s Valuation As Shares Mix Short Term Weakness With Strong One Year Returns
What AstraZeneca’s Recent Returns Tell You About Market Expectations
AstraZeneca (LSE:AZN) has drawn attention after a period where the share price showed a small 1 day decline, a mid single digit fall over the past week, and gains over the past month and past 3 months.
For investors, that mix of short term weakness and recent positive returns sits alongside a £144.92 last close, a value score of 3, and an implied intrinsic discount of 39%. This raises questions about how the current price...